An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.

A synthetic form of the active ingredient in cannabis helps reduce agitation ... dementia. Nine out of 10 develop behavior problems, and agitation is the most common, affecting 4 in 10. Agitated ...

"It is the agitation, not the memory loss, that often drives individuals with dementia ... in this patient population currently on the market," Forester said. A pilot study had suggested that ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

“Agitation is one of the most distressing symptoms of Alzheimer’s dementia, and we are pleased to make positive strides forward in treatment of these patients.” Alzheimer’s disease is the ...